Research ArticleBIOMATERIALS

Percutaneous liquid ablation agent for tumor treatment and drug delivery

See allHide authors and affiliations

Science Translational Medicine  10 Feb 2021:
Vol. 13, Issue 580, eabe3889
DOI: 10.1126/scitranslmed.abe3889

Article Information

vol. 13 no. 580

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication August 18, 2020
  • Accepted for publication January 15, 2021
  • .

Author Information

  1. Hassan Albadawi1,
  2. Zefu Zhang1,
  3. Izzet Altun1,
  4. Jingjie Hu1,
  5. Leila Jamal1,
  6. Kelly N. Ibsen2,
  7. Eden E. L. Tanner2,*,
  8. Samir Mitragotri2, and
  9. Rahmi Oklu1,
  1. 1Minimally Invasive Therapeutics Laboratory, Department of Vascular and Interventional Radiology, Mayo Clinic, Phoenix, AZ 85054, USA.
  2. 2John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, USA.
  1. Corresponding author. Email: oklu.rahmi{at}mayo.edu (R.O.); mitragotri{at}seas.harvard.edu (S.M.)
  • * Present address: Department of Chemistry and Biochemistry, University of Mississippi, 179 Coulter Hall, Oxford, MS 38677, USA.

Altmetric

Article usage

Article usage: February 2021 to June 2021

AbstractFullPdf
Feb 2021116571345544
Mar 2021901169140
Apr 202142411091
May 20213498850
Jun 20211253526

Stay Connected to Science Translational Medicine